Dr Abdullah Ansari
PG-2 (Medicine)
AMU ALIGARH
A general approach to periodic paralysis....
(including hypokalemic periodic paralysis and thyrotoxic periodic paralysis, and other “Channelopathies” or “Membranopathies)
Pathophysiology
Epidemiology
Primary or familial periodic paralysis
Secondary periodic paralysis
Conventional classification of periodic paralysis
Classification of primary periodic paralysis based on ion-channel abnormalities
Clinical approach to a case of periodic paralysis
History of muscle weakness
Age of onset
Family history
Timing
Intensity
History of administration of certain drugs
Clinical examination
Differential Diagnosis
Laboratory investigations
Serum K+
CPK and serum myoglobin
ECG
EMG
Nerve conduction studies
Provocative Testing
Muscle biopsy
Treatment
Prognosis
Coma is defined and the anatomy of consciousness explained. The various levels of arousal, AVPU scale and Glasgow Coma Scale described. The differential diagnosis of coma discussed are coma with & without focal deficits and the meningitis syndrome.
The various aspects of history discussed in details. The examination part includes the general examination, Brainstem reflexes, motor functions with the signs of lateralisation and meningeal irritation signs.
The basic lab investigations, Imaging and special investigations like CSF examination, EEG discussed.
Elevated intracranial pressure and its management explained.
Dr Abdullah Ansari
PG-2 (Medicine)
AMU ALIGARH
A general approach to periodic paralysis....
(including hypokalemic periodic paralysis and thyrotoxic periodic paralysis, and other “Channelopathies” or “Membranopathies)
Pathophysiology
Epidemiology
Primary or familial periodic paralysis
Secondary periodic paralysis
Conventional classification of periodic paralysis
Classification of primary periodic paralysis based on ion-channel abnormalities
Clinical approach to a case of periodic paralysis
History of muscle weakness
Age of onset
Family history
Timing
Intensity
History of administration of certain drugs
Clinical examination
Differential Diagnosis
Laboratory investigations
Serum K+
CPK and serum myoglobin
ECG
EMG
Nerve conduction studies
Provocative Testing
Muscle biopsy
Treatment
Prognosis
Coma is defined and the anatomy of consciousness explained. The various levels of arousal, AVPU scale and Glasgow Coma Scale described. The differential diagnosis of coma discussed are coma with & without focal deficits and the meningitis syndrome.
The various aspects of history discussed in details. The examination part includes the general examination, Brainstem reflexes, motor functions with the signs of lateralisation and meningeal irritation signs.
The basic lab investigations, Imaging and special investigations like CSF examination, EEG discussed.
Elevated intracranial pressure and its management explained.
Hypertension Emergencies and their managementpptxUzomaBende
This Presentation talks about Hyprtension, the mode of presentation of hypertensive crisis and the effective management of hypertensive crisis to prevent case fatalities.
Parkinson Plus Syndrome - Multiple System Atrophy: Case Report.
Poster used in CMC MAC 2021.
ABSTRACT
A 61yr/Male, K/C/O T2DM & Parkinson’s disease(PD) on T.Metformin and T.Syndopa for 3 years, presented to us with complaints of unsteadiness of gait, dysarthria, bilateral upper limb tremor. These symptoms started gradually and has been there for last 3 years and it is progressive. Initially, it started as inability to write and difficulty in mixing food due to tremulousness of both hands which worsens with activity. Then it progressed to slurred speech and then to gait unsteadiness. Patient also has urinary incontinence for last 2 years. Patient’s symptoms are more in severity for last 6 months. On examination, patient was having orthostatic hypotension, cogwheel rigidity on bilateral wrist movement and pendular knee jerks. All cerebellar signs were present bilaterally including finger nose test abnormality, past pointing, dysdiadochokinesia, heel shin test abnormality, gross truncal ataxia, wide based gait, impaired tandem walking, gaze evoked nystagmus, scanning speech.
Presence of cerebellar signs, autonomic disturbances, poor response to syndopa, rapid progression, lack of resting tremor at presentation, symmetrical involvement, early speech and gait involvement - are usually NOT seen in PD. So, evaluated further. MRI Brain T2 showed classical cruciform hyperintensity in pons (Hot cross bun sign) & diffuse cerebellar atrophy. Hence the diagnosis MULTIPLE SYSTEM ATROPHY (MSA-C) - Shy Drager Syndrome. This shows the importance of identifying atypical features in PD.
Allergy Induced Acute Coronary Syndrome - Kounis Syndrome: Case Report.
Poster used in CMC MAC 2021.
OBJECTIVE: To discuss a rare occurrence of allergic reaction to NSAID causing Myocardial Infarction.
BACKGROUND: A 21-year-old obese female with no other comorbidities was referred to us with history of chest pain, generalized urticarial rashes and itch suddenly following Inj.IM Diclofenac, which was given for heel pain relief. She was hemodynamically stable, but tachypneic, orthopneic and was having bilateral basal crepitations. ECG revealed significant ST depression & T inversion in II,III,aVF and V2-V6 and ST elevation in aVR. CXR showed pulmonary edema. Diagnosed as ACS following anaphylaxis and loading dose was given along with IM adrenaline, antihistamines, and steroids. Echo revealed global hypokinesia of LV. Cardiac enzymes were elevated. Meanwhile, she had a prompt relief of chestpain, but dyspnea worsened and warranted NIV support. Repeat ECG revealed regression of ST changes correlating with chest pain relief. After 2 days of NIV, patient’s dyspnea improved and weaned from NIV. CAG revealed normal epicardial coronaries. Serial cardiac enzyme levels showed falling trend and ECG was completely normal with no significant ST-T changes. Pre-discharge, repeat echo showed persistence of global hypokinesia. 2weeks later, repeat echo showed dramatic improvement with normal LV systolic function suggesting recovery from myocardial stunning.
RESULTS: This qualifies for the diagnosis of MINOCA (Myocardial Infarction with No Obstructive Coronary Arteries). In the setting of allergic trigger, vasospasm or coronary hypersensitivity is the underlying mechanism- described as KOUNIS SYNDROME.
CONCLUSION: ECG changes and chest discomforts that occur in allergic reactions are not always secondary to distributive/anaphylactic shock. Sometimes heart could be the primarily affected organ by the allergic reaction as in this case. Although <200cases reported globally until 2017, it’s suspected to be frequently overlooked, hence likely to be more prevalent.
Case Report: Brugada Syndrome - A Cardiac Channelopathy.
Poster used for presentation in CMC MAC 2021.
OBJECTIVE: To discuss an interesting case of Brugada syndrome presenting as seizures.
BACKGROUND: A 25-year-old well-informed male presented to us with complaints of seizure on day 3 of an acute febrile illness. He was conscious, oriented, GCS15/15 and system examinations were unremarkable. He had a similar history of seizure during fever 1 year back and was started on anti-epileptics since then and was treated with empirical antibiotics and CSF analysis, MRI brain with seizure protocol and EEG were completely normal during that episode. As described by patient, both episodes were very similar and was like darkening of visual field followed by LOC and bystanders witnessed few jerks involving both sides of body followed by regaining consciousness. This raised suspicion for syncope and ECG revealed RBBB-rSR’ pattern and saddleback STE in V1-V3(type2-brugada pattern-not diagnostic on its own). But on probing, patient revealed SCD in his father at age 42.
RESULTS: Echo revealed structurally normal heart. Expert opinion sought and flecainide challenge test revealed the classical type1 brugada pattern (diagnostic) with coved STE and T inversion in V1-V3 clinching the diagnosis of BRUGADA SYNDROME. Genetic testing for channelopathy was unremarkable. Type 1 Brugada pattern (on provocative testing) along with syncopal event and family history strongly warranted AICD insertion and patient opted for subcutaneous ICD. 6 months later, ICD interrogation revealed occurrence of 1 episode of NSVT, which fell below the ICD intervention threshold.
CONCLUSION: Brugada syndrome is a rare cardiac channelopathy with high risk of SCD in the absence of intervention. Events during fever and family history are very classical. It has male preponderance and more seen in Southeast Asia. All cases of suspected syncopal attacks warrant a thorough search for ECG markers of SCD.
Case Presentation PPT - For TAPICON 2021
Case Report: Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensitivity Disorder / Vasospastic Angina.
Abstract
A young female with no coronary risk factors presented to us with history of chest pain, generalized urticarial rashes and itch suddenly following Inj.IM Diclofenac, which was given for heel pain relief. She was hemodynamically stable, but tachypneic, orthopneic with bilateral basal crepitations.
ECG showed significant ST depression & T inversion in II,III,aVF and V2-V6 and ST elevation in aVR. CXR showed pulmonary edema. Echo revealed global hypokinesia of LV. Cardiac enzymes were elevated. Treated for acute coronary syndrome (ACS) and her pain got relieved. CAG showed normal epicardial coronaries. Repeat ECG showed regression of ST changes correlating with chest pain relief and enzymes were also falling.
Pre-discharge, ECG normalised but echo showed persistence of global hypokinesia. Two weeks later, repeat echo showed dramatic improvement with normal LV systolic function suggesting recovery from myocardial stunning.
This qualifies for the diagnosis of MINOCA (Myocardial Infarction with No Obstructive Coronary Arteries). In the setting of allergic trigger, vasospasm or coronary hypersensitivity is the underlying mechanism - described as KOUNIS SYNDROME.
ECG changes and chest discomforts that occur in allergic reactions are NOT ALWAYS SECONDARY to distributive/anaphylactic shock. Sometimes heart could be the primarily affected organ by the allergic reaction. It is frequently overlooked and its timely recognition and appropriate intervention will improve the outcome.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
1. ALLERGIC ACUTE CORONARY SYNDROME
By
Dr.K.Manievelraaman
Second Year PG
IIM, MMC & RGGGH
UNIT M1
Prof.Dr.C.Hariharan MD
Not a rare disease occurrence
But a rarely identified one
2. History
• Ms.V, a 21 year old female
• Resident of Chennai
• Unmarried
• Educated
• Well Built and Nourished
• No known co-morbidities
• Otherwise healthy person
• Never had a chest discomfort
• Never had any symptoms suggestive of cardiac or pulmonary
pathology
3. History - Continued
• History of outside food ingestion the previous day
• Visited nearby Private clinic for colicky abdominal pain – Intermittent and each
episode lasted <5mins
• Received Inj. Diclofenac I.M for pain relief
• After 10-15 mins of IM Injection, Patient developed
• Chest discomfort – retrosternal; tightness; non-radiating
• Urticarial rashes all over the body
• Giddiness
• IM Adrenaline 0.5cc given and IV Fluids started
• After 2 hours of observation, symptoms persisted; Patient referred to higher centre
4. On Arrival
• History noted
• Vitals checked
• BP: 90/60 mm of Hg
• HR: 120 beats/min
• RR: 24/min
• SpO2: 98 with Nasal O2
• Hypotension present
• Second shot of IM Adrenaline 0.5cc given along with isotonic fluid bolus
5. After an hour
• C/O Breathlessness developed –
• Worsened by lying flat (orthopnea)
• Lying flat elicits cough
6. Relevant Negative History
• No H/O Palpitations, Pedal edema, Abdominal distension
• No H/O dysphagia, vomiting, loose stools, LGI bleed, constipation, obstipation
• No H/O oliguria, dysuria
• No H/O LOC, Seizures
• No H/O suggestive of Rheumatologic Illness
• Personal H/O – No adverse social habits; No history of drug abuse
• Family H/O – No family history of MI, SCD.
• Previous H/O – No previous episodes of urticaria, drug allergy.
7. On Examination
• HR:96/min; BP:90/60mm Hg; RR:24/min; SpO2:98 on O2; JVP- not elevated
• Conscious, Oriented, Afebrile, Tachypneic
• NO {pallor, icterus, cyanosis, clubbing, lymphadenopathy, pedal edema}
• CVS – S1S2+ ; No murmur
• RS – Scattered Wheeze+ (expiratory); Bilateral Crackles+
• PA – soft; non tender; no organomegaly; no guarding/rigidity
• CNS – Conscious, Oriented; B/L pupils reactive; No focal deficits
23. Controversies and Substantiations
• Could ADRENALINE be the reason for ECG changes?
• Could SHOCK explain all these?
• Could initial abdominal pain itself be of cardiac origin?
26. Why adrenaline less likely cause?
• NO TACHYCARDIA IN INITIAL ECG ( HR<100/min )
• Second dose of Adrenaline didn’t worsen it, rather ECG showed
regression of ischemic changes.
• Half life of adrenaline.
27. • On Discharging,
• Patient BP was 90/60 mm Hg
• No tachycardia
• No Tachypnea
• No Dyspnea
• No orthopnea
• When in IMCU,
• IVC diameter was 1.8cm
• Also, Colicky (Intermittent) nature of pain is unlikely to be of cardiac origin
34. Inflammatory mediators - Cause or Result?
• Mast cell infiltration
• Circulating precursors
• Stress test induced Ischemia not accompanied by surge
• No histamine elevation with Acetylcholine induced vasospasm
35. Myocardial Ischemia – Primary or Secondary?
• Differentiation is clearly challenging; Both may co-exist
Systemic
vasodilation
Increased vascular
permeability
Decreased Venous
Return
Reduced CO
Coronary
hypoperfusion
Antigen
administration
ECG signs of
Myocardial
Ischemia
LVEDP rapidly
increased
BP started
declining
steadily after 4
mins
Unlikely in the
setting of decreased
venous return
36. Why not in all allergic episodes?
• Threshold level
• Baseline elevation à high risk
• Underlying mast cell disorder à high risk
• Increased incidence of IHD in atopic individuals and wheezers
• Use of ICS a/w reduced risk of IHD in asthmatics
41. Terminologies
• Obstructive Epicardial coronaries
• Non-Obstructive Epicardial coronaries
• Vasospasm à Prinzmetal’s Angina
• No vasospasm but persisting ECG findings of ischemia
à cardiac syndrome X
• ( ? Microvascular pathology )
Developing
in the
setting of
Allergy
+
42. Treatment options for KOUNIS SYNDROME
• Type 1 variant à Steroid, Antihistamine, Vasodilator, Mast Cell Stabilizers
• Type 2 variant à Standard ACS Rx protocol + Above
• Type 3 variant à Same as above + Aspiration of Intrastent thrombus
43. • Ranitidine may have a role.
• Due to it’s paraspecific action on H1 blockade.